Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs34625609 | chr2:241766873 | C/T | 0.000189 | 488 | 29.4 | 32.7 | 32.63 | KM Plot |
PRAD | rs34630219 | chr16:5003436 | C/T | 4.84E-5 | 475 | 31.27 | 29.63 | 27.77 | KM Plot |
PRAD | rs34669484 | chr8:71962261 | A/G | 3.98E-5 | 494 | 24.27 | 30.77 | 31.23 | KM Plot |
PRAD | rs34678364 | chr2:178800097 | T/G | 4.51E-5 | 492 | 30.73 | 31.93 | 20.48 | KM Plot |
PRAD | rs34679468 | chr2:241774804 | C/T | 7.4E-6 | 481 | 29.32 | 32.5 | 30.38 | KM Plot |
PRAD | rs34695799 | chr8:143380236 | G/A | 6.55E-5 | 483 | 30.93 | 31.87 | 28.13 | KM Plot |
PRAD | rs34700572 | chr2:239100584 | C/A | 9.24E-10 | 471 | 31.68 | 28.93 | 30.45 | KM Plot |
PRAD | rs34702628 | chr7:6763386 | G/A | 3.44E-7 | 488 | 31.18 | 26.7 | 50.03 | KM Plot |
PRAD | rs34705845 | chr1:93614709 | T/TGAA | 1.11E-8 | 492 | 9.17 | 28.13 | 31.37 | KM Plot |
PRAD | rs34717744 | chr2:178797523 | C/T | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs34730405 | chr2:107434931 | T/TA | 1.38E-5 | 491 | 30.93 | 30.7 | 32.63 | KM Plot |
PRAD | rs34735 | chr5:96166064 | A/G | 7.17E-5 | 494 | 31.37 | 30.78 | 24.13 | KM Plot |
PRAD | rs34747248 | chr2:178800104 | A/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs34751899 | chr8:71552302 | C/A | 4.75E-5 | 492 | 31.08 | 31 | 24.27 | KM Plot |
PRAD | rs34763766 | chr4:98732692 | TA/T | 4.49E-6 | 491 | 31.13 | 28.98 | 45.12 | KM Plot |